A new wave of Covid-19 lockdowns combined with the usual winter slump in traffic will push more airlines toward the brink, says one analyst.
The UK is expected to receive a total of 40 million doses by the end of 2021, enough to vaccinate up to a third of the population, with the majority of doses anticipated in the first half of next year
Pfizer and Moderna may have an initial advantage in dealing with manufacturing challenges, as their novel messenger RNA technology can be scaled up.
Coronavirus live updates: At 1,780,208, Maharashtra has the highest number of coronavirus cases, followed by Karnataka 873,046, Andhra Pradesh 862,000, Tamil Nadu 769,000 and Kerala 562,735
A vaccine developed by AstraZeneca and the University of Oxford prevented 70% of people from developing the coronavirus in late-stage trials, and more top headlines of the day
AstraZeneca says late-stage trials of its Covid-19 vaccine were highly effective'' in preventing disease.
The company plans to keep the "active" drug substance in stock while it awaited regulatory approval around the world
An FDA vaccine advisory committee is slated to meet December on 10
India had been witnessing more recoveries as compared to daily new case additions resulting in a drop in active cases count.
Wealthy nations won't waive IPR rules for Covid drugs, Why Covid spikes in some places, study says reinfection unlikely for six months at least-news on how the country is coping with the pandemic
South Korea toughens social distancing norms, Europe plans cautious easing of lockdown, UK starts trials for antibody cocktail, and other pandemic-related news across the globe
There is a wide variation in the spread of COVID-19 between states. Areas with higher population density are expected to have more cases, but varying testing rates could be affecting case detection
With 44,059 new cases of Covid-19 infections, India's tally mounted to 91,39,865 on Monday
Testing half the population weekly with inexpensive, rapid-turnaround Covid-19 tests would drive the virus toward elimination within weeks, claim researchers
The overall number of global coronavirus cases has topped 58.5 million, while the deaths have surged to more than 1.38 million, according to the Johns Hopkins University
India is likely to issue an emergency use authorisation to at least one Covid vaccine by the end of January and health workers will be the first to be inoculated. More headlines in our evening roundup
Discuss efforts to ensure fair distribution of a coronavirus vaccine globally
Moderna has said its experimental vaccine is 94.5% effective in preventing Covid-19, based on interim data from a late-stage clinical trial.
AstraZeneca vaccine is likely to cost Rs 500-600 per dose in the private market
Air freight stations near manufacturing sites will enable direct movement of vaccines to the aircraft